News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Linscott Walt Addison
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/20/2023 |
4
| Linscott Walt Addison (Chief Business Officer) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.61, valued at
$64.4k
|
|
| 09/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| Linscott Walt Addison (Chief Business Officer) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 45,850 options to buy
@ $4.9, valued at
$224.7k
|
|
| 08/06/2021 |
4
| Linscott Walt Addison (Chief Business Officer) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 210,000 options to buy
@ $8.87, valued at
$1.9M
|
|
| 08/02/2021 |
3
| Linscott Walt Addison (Chief Business Officer) has filed a Form 3 on Intec Parent Inc. |
| 09/18/2020 |
4
| Linscott Walt Addison (Chief Business Officer) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 100,000 options to buy
@ $0.3215, valued at
$32.2k
|
|
| 02/19/2020 |
4
| Linscott Walt Addison (Chief Business Officer) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 90,000 options to buy
@ $0.4287, valued at
$38.6k
|
|
| 09/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2019 |
4
| Linscott Walt Addison (Chief Business Officer) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 90,000 options to buy
@ $7.628, valued at
$686.5k
|
|
| 01/02/2019 |
3
| Linscott Walt Addison (Chief Business Officer) has filed a Form 3 on Intec Pharma Ltd. |
|
|